title: Prolongation of porcine islet xenograft survival in mice after therapy with immunosuppressive peptides.
abstract: BACKGROUND
  Recently, peptides derived from the heavy chain of HLA-B2702 have been shown to modulate immune responses. In this study, we examined the use of these peptides for immunosuppression in a pig to mouse islet xenograft model.
  
  
  METHODS
  Purified porcine islets were transplanted in autoimmune (non-obese diabetic) and non-autoimmune (streptozotocin-injected CBA or C57/Bl6) diabetic mice. Various dosing regimens of HLA-derived peptides with and without antilymphocyte therapy were administered to recipient mice. Graft rejection was determined by daily serum glucose determinations, and, at selected time points, grafts were removed to demonstrate function and provide immunohistochemical examination.
  
  
  RESULTS
  HLA-derived peptides were demonstrated to prolong graft survival in both pretransplant and posttransplant treatment regimens. This effect was increased with concomitant antilymphocyte therapy.
  
  
  CONCLUSIONS
  Further elucidation of the mechanism of action of these immunomodulatory peptides may help in the development of novel immunosuppressive protocols.
authors.affiliation: Department of Surgery, State University of New York Health Science Center, Syracuse, New York 13210, USA. esquiers@sangstat.com
authors.forename: E C
authors.initials: EC
authors.lastname: Squiers
authors.forename: M
authors.initials: M
authors.lastname: Hodell
authors.forename: D
authors.initials: D
authors.lastname: Tice
authors.forename: R
authors.initials: R
authors.lastname: Buelow
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D006085:Graft Survival / Q000187:drug effects; D006419:Heme Oxygenase (Decyclizing) / Q000502:physiology; D006649:Histocompatibility Antigens / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016381:Islets of Langerhans Transplantation / Q000276:immunology*; D051379:Mice; D008808:Mice, Inbred CBA; D016688:Mice, Inbred NOD; D013552:Swine; D014183:Transplantation, Heterologous; D015854:Up-Regulation
chemical_list: D000276:Adjuvants, Immunologic; D000961:Antilymphocyte Serum; D006649:Histocompatibility Antigens; D007166:Immunosuppressive Agents; D006419:Heme Oxygenase (Decyclizing)